GAMMA Investing LLC Raises Holdings in Eli Lilly and Company

Institutional investor increases stake in pharmaceutical giant

Mar. 21, 2026 at 8:07am

Got story updates? Submit your updates here. ›

GAMMA Investing LLC, an institutional investor, increased its holdings in Eli Lilly and Company (NYSE:LLY) by 27.0% in the fourth quarter, according to a recent disclosure with the Securities & Exchange Commission. The firm now owns 21,821 shares of the company's stock, making it one of Eli Lilly's top 12 institutional investors.

Why it matters

This investment move by GAMMA Investing highlights the continued institutional interest and confidence in Eli Lilly, one of the world's leading pharmaceutical companies. As Eli Lilly advances its drug pipeline and expands its commercial footprint, its stock has become an attractive target for major institutional investors seeking exposure to the healthcare sector.

The details

According to the SEC filing, GAMMA Investing LLC increased its position in Eli Lilly by adding 4,641 additional shares during the fourth quarter. This brings the firm's total holdings in Eli Lilly to 21,821 shares, which represent approximately 1.2% of GAMMA's overall investment portfolio.

  • GAMMA Investing LLC increased its Eli Lilly holdings in the fourth quarter of 2026.

The players

GAMMA Investing LLC

An institutional investor that has increased its stake in Eli Lilly and Company.

Eli Lilly and Company

A global pharmaceutical company founded in 1876 and headquartered in Indianapolis, Indiana.

Got photos? Submit your photos here. ›

The takeaway

GAMMA Investing's increased investment in Eli Lilly reflects the pharmaceutical company's strong performance and growth potential in the eyes of major institutional investors. As Eli Lilly continues to advance its drug pipeline and expand its commercial reach, it remains an attractive option for investors seeking exposure to the healthcare sector.